Physician profile
Roberta J Hawk
NPI 1093828378
$3,190.74
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $103 · 2021: $611 · 2022: $861 · 2023: $739 · 2024: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.46 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,346.16 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $284.03 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $181.60 | 2022-2024 | Sotyktu |
| Janssen Biotech, INC. | $170.51 | 2019-2024 | Tremfya |
| Lilly USA, LLC | $169.49 | 2019-2023 | Olumiant, Taltz |
| Genzyme Corporation | $167.60 | 2019-2023 | |
| Galderma Laboratories, L.P. | $158.65 | 2019-2024 | Aklief |
| Regeneron Healthcare Solutions, INC. | $119.52 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $84.90 | 2019-2024 | Odomzo, Blu-U |
| Leo Pharma INC. | $78.05 | 2019-2022 | |
| Dermavant Sciences, INC. | $75.88 | 2022-2023 | Vtama |
| Strata Skin Sciences, INC. | $68.90 | 2019-2021 | |
| Pfizer INC. | $57.30 | 2022-2024 | |
| Ucb, INC. | $45.75 | 2019-2021 | |
| Amgen INC. | $44.83 | 2022-2023 | Otezla |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.97 | 2023 | Spevigo |
| Arcutis Biotherapeutics, INC. | $28.48 | 2023 | |
| Almirall LLC | $18.44 | 2019 | |
| Nabriva Therapeutics, Plc | $15.94 | 2022 | |
| Vyne Pharmaceuticals INC. | $15.14 | 2021 | |
| Dusa Pharmaceuticals, INC. | $12.48 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberta Hawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.